Search results
-
Blog
Case Study: Innovative Nanosuspension Approach to Maximize API Potency in Preclinical Formulation Development
Altasciences helped a client develop a robust preclinical formulation prototype at the maximum potency for their API BSC Class II compound.
-
-
-
Blog
Case Study: How to Evaluate Human Abuse Potential (HAP) for CNS Drugs
Altasciences supported a client with HAP studies for the development of a novel analgesic, mirogabalin, currently marked in Japan, Korea, Taiwan, and China.